<DOC>
	<DOCNO>NCT00038922</DOCNO>
	<brief_summary>To explore safety orally deliver rhIL-11 patient mild moderate left-sided ulcerative colitis . To explore effect orally administer rhIL-11 pharmacogenomics blood sample colonic biopsy tissue sample .</brief_summary>
	<brief_title>Study Evaluating rhIL-11 Left-Sided Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Oprelvekin</mesh_term>
	<criteria>Documented , sign inform consent participate study Age great equal 18 year Documented diagnosis ulcerative colitis standard clinical criterion , include endoscopy ( either flexible sigmoidoscopy colonoscopy , sufficient define proximal limit disease ) biopsy Crohn 's disease Ulcerative proctitis Ulcerative colitis extend beyond splenic flexure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Left-Sided</keyword>
	<keyword>Ulcerative</keyword>
	<keyword>Colitis</keyword>
</DOC>